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Glucose is a starting material for nearly all biosynthetic reactions 
in our body. Using glucose, cells generate adenosine triphosphate 
(ATP), the main source of energy in our body, through glycolysis and 
mitochondria. Excess glucose is stored as glycogen for future use. Not 
like other parts of the body, the brain cannot store glucose and mostly 
depends on the glucose in the bloodstream. Therefore, it is important to 
maintain a constant level of blood glucose, which process is known as 
glucose homeostasis. Glucose homeostasis is regulated mainly by 
pancreatic hormones. Food intake triggers a rise in blood glucose levels, 
which is monitored by pancreas. The pancreas releases a hormone, 
insulin, which brings glucose to the tissues for respiration or to the liver 
glycogenesis, in which the glucose is stored as glycogen. During the 
fasting state, the other hormone glucagon promotes hepatic glucose 
production (also known as glycogenolysis), which raises the dropped 
blood glucose level back to the normal range. Effects of both hormones 
are critical for the glucose homeostasis, but the homeostasis is mainly 
regulated by insulin. 
Glucose-stimulated insulin secretion in β-cells is mediated 
through ATP-sensitive K+ (KATP)-dependent pathway. Once the cell 
detects high glucose in the plasma, glucose is transported into the cell 
via glucose transporter 2 (GLUT2) and metabolized by glycolysis 
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increasing the intracellular ATP/ADP ratio. This leads to the closure of 
KATP channels, which in turn depolarizes membrane potentials and 
activates voltage-gated Ca2+ channels (VGCC). Increased cytoplasmic 
Ca2+ level triggers Ca2+-dependent exocytosis of insulin granules. 
Although the main triggering pathway for insulin secretion is KATP 
channel-dependent pathway, involvement of KATP channel-independent 
β- cell depolarization in response to high extracellular glucose level has 
been also proposed. One of candidate mechanisms for the latter 
pathway derived insulin secretion is that high glucose concentration not 
only depolarizes membrane potential of the β-cells via KATP channel, but 
also induces cell inflation, which process is described as swelling-
stimulated insulin secretion. Many studies have shown that β-cell 
swelling, upon glucose or hypotonic stimulations, is sufficient to release 
insulin granules through ion channels such as volume regulated anion 
channels and/or stretch activated cation channels, that sense stretch of 
β-cell membrane and develop depolarization. Recently, the molecular 
identity of the anion channel was found to be SWELL1 (83), however, 
the molecular identity for the stretch-activated cation channel 
responsible for swelling-stimulated insulin secretion in β-cells remains 
unknown.  
Recently our lab identified a new mechanosensitive cation 
channel, Tentonin 3 (TTN3/ TMEM150c), that mediates slowly adapting 
currents in various neurons. Interestingly, along with dorsal-root ganglia 
neuron, it is highly expressed in pancreas. In the present study, we 
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determined whether TTN3 plays a functional role in pancreas and 
possible involvement in the glucose-stimulated insulin secretion by 
mediating cation influx to hypotonic stimulation. We discovered that 
TTN3 is expressed in mouse pancreatic β-cells and mediates 
mechanosensitive responses. As glucose-induced swelling is a well-
known mechanical stimuli in pancreas, we further assessed the activity 
of TTN3 to high glucose- or hypotonic-stimulations. Both of glucose- and 
hypotonic stimulations induced cationic currents in isolated pancreatic 
β-cells, and the response was significantly reduced in Ttn3 KO β-cells. 
In addition, genetic ablation of Ttn3 showed decreased electrical activity 
and Ca2+ influx in β-cells to those stimulations. Moreover, Ttn3 KO mice 
showed impaired glucose tolerance with decreased insulin secretion in 
vivo. Here we propose that TTN3, as a stretch-activated cation channel, 
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1. Glucose Homeostasis 
1.1. Overview 
Our body needs energy to function, and the energy comes from 
the food we eat. Glucose, which comes from an ancient Greek word 
gleukos, meaning “sweet”, refers to a type of sugar (2). It is also called 
blood glucose as it travels through bloodstream to cells throughout the 
body (3).  
 
1.2. Glucose Production 
The body derives glucose from three different sources; dietary 
sources, the product of the breakdown of glycogen (glycogenolysis), or 
the synthesis of glucose from other carbon compounds 
(gluconeogenesis) (4). After food intake, the carbohydrates in the food 
we eat are digested in the stomach into monosaccharides such as 
galactose, fructose and glucose. Among them glucose constitutes 80 
percent of monosaccharides (5). Transferred down into small intestine, 
glucose is absorbed by absorptive cells. Excess glucose is stored in liver 
as glycogen or converted to triglycerides and stored in adipose tissue 
(6). During the early phase of starvation, glycogenolysis in the liver or 
muscle cells is the primary source of glucose. Drop of blood glucose 
level, adrenal gland secretes epinephrine (adrenaline), growth hormone 
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and cortisol (7). Upon the stimulation by epinephrine, hepatocytes in the 
liver activate glycogen breakdown and release glucose into the 
bloodstream (8). Over longer periods of fasting, our body depends on 
the gluconeogenesis in the liver or kidneys. Glucose is synthesized from 
non-carbohydrate precursors such as lactate, glycerol, amino acids (9). 
 
1.3. Glucose Utilization 
Cells use glucose to create energy through glycolysis (anaerobic 
respiration) and/or pyruvate oxidation (anaerobic respiration). Glycolysis 
is the first pathway in cellular respiration and takes place in the 
cytoplasm of the cell. It breaks down 1 glucose molecule and produces 
2 pyruvate molecules and 2 adenosine triphosphate (ATP) (10). The 
pyruvate generated by glycolysis is oxidized in the aerobic respiration 
that takes place in the mitochondria. The mitochondria uses oxygen to 
burn the pyruvate into heat and ATP, which is the major energy molecule 
of the cell (7). The organs accounting most of glucose uptake in our body 
are as follows: the brain (45-60%), skeletal muscle (15-20%), blood cells 
(5-10%), splanchnic organs (3-6%), and adipose tissue (2-4%) (11).  
 
1.4. Significance of Glucose Homeostasis 
The brain relies almost exclusively on glucose for its source of 
energy, as ATP is critical for neuronal and non-neuronal cellular 
maintenance, as well as the generation of neurotransmitters (12, 13). 
Unlike other parts of the body which store glucose as fat or glycogen, 
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the brain cannot store glucose more than a few minutes- supply, so it is 
critical for brain to receive a continuous supply of glucose through 
bloodstream. (4, 14)  
 
1.5. Regulation of Glucose Homeostasis 
Blood glucose levels fluctuate according to the status of our body, 
which is monitored by pancreas. The concentration of blood glucose 
drops to 50 mg/dl, when prolonged fasting, and rises up to 165 mg/dl 
after food intake in a healthy man. However, tightly regulated glucose 
homeostasis in our body maintains the average value within a narrow 
range, 70 ~ 110 mg/dl (4, 6). 
There are many factors regulating the concentration of blood 
glucose; hormones, the sympathetic nervous system activity as well as 
the concentration of other nutrients, and exercise which may affect the 
sensitivity to hormones (4). 
 
1.5.1. Pancreas  
 The pancreas is an abdominal organ located behind the 
stomach. The pancreas is made up of two kinds of glands with two 
primary functions; exocrine gland and endocrine gland as shown in 
Figure 1 (15). As an exocrine gland, acinar cells or exocrine cells in the 
pancreas regulates macronutrient digestion by releasing digestive 
enzymes such as amylase, pancreatic lipase and trypsinogen, into the 
ducts (16). In contrast, as an endocrine gland, four specialized cell 
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types, glucagon producing α-cells, amylin-, C-peptide- and insulin-
producing β-cells, pancreatic polypeptide (PP)-producing γ-cells, and 
somatostatin-producing δ-cells, organized into a compact islet called an 
islet of Langerhans, secrete hormones into bloodstream and maintains 
glucose homeostasis (15). Changes in concentration of blood is 
monitored by the pancreas through its various hormones, the pancreas 
maintains blood glucose level within a narrow range (16).  
 
1.5.2. Hormonal regulation of glucose homeostasis  
The concentration of glucose in the bloodstream is mainly 
regulated by hormones by conducting storage and the utilization of 
glucose as required (6). The pancreas, after monitoring the blood 
glucose levels, secrete glucose regulatory hormones including insulin, 
glucagon, amylin, glucagon-like peptide-1 (GLP-1), gastric inhibitory 
polypeptide (GIP), epinephrine, cortisol, and growth hormones to 
maintain normal levels (17). Among them, the role of glucagon and 
insulin plays a key role in glucose homeostasis as described in Figure 
2. In the fed state, the pancreas releases insulin which delivers glucose 
to the tissues for respiration or promotes glycogen synthesis in the liver 
and muscle and lipid formation in adipocytes. During the fasting state, 
however, the pancreas releases another hormone, glucagon, which 
stimulates hepatic glucose production from glycogen breakdown and 




Figure 1. Cross section of the pancreas 













Figure 2. Homeostatic regulation of blood glucose level 
Adapted from (6) 
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1.5.2.1. Insulin  
Insulin is a key anabolic hormone that is secreted by pancreatic 
β-cells in response to high blood glucose level. Insulin brings glucose to 
tissues for respiration or to the liver where the glucose is stored as 
glycogen. By promoting glucose uptake by cells throughout your body 
for respiration and protein and fat synthesis while suppressing glucagon 
secretion or by signaling the body to store excess glucose in the liver, 
insulin lowers the concentration of glucose in the blood (19). The stored 
glycogen is not released until the blood glucose levels fall below the 
normal range (20). As insulin plays the main role in glucose 
homeostasis, making and releasing the right amount of insulin according 
to the blood glucose level and responding properly to insulin are 
important for the maintenance of glucose homeostasis (16). When there 
is too little insulin (termed hypoinsulinemia), it results in high blood 
glucose levels. Excess glucose spills into the urine, which leads to 
dehydration (21). In addition, the cells cannot use glucose for energy 
and make new energy from fat which makes acids as waste products. 
Eventually, this can lead to coma and death if one does not receive 
medical attention (22).  
On the contrary, when there is too much insulin (termed 
hyperinsulinemia), this leads to abnormally low blood glucose levels, 
which is called hypoglycemia. If it is not treated promptly, it will affect the 
brain, which depends almost entirely on blood glucose as a source of 
energy. Ultimately, it can cause dizziness and even coma (23).          
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Producing the right amount of insulin is important, but responding 
properly to insulin is also significant factor for keeping the blood glucose 
level in a narrow range. When cells stop responding to insulin, the 
condition is called insulin resistance (24). Even though there is enough 
insulin available in the blood, our body is resistant to insulin or has low 
insulin sensitivity, both insulin and blood glucose levels rises. As this 
condition continues for a long time, the pancreas fails to keep up with 
the increasing blood glucose and may become damaged (25).     
 
1.5.2.2. Glucagon  
Glucagon is a key catabolic hormone secreted from pancreatic 
α-cells. It maintains plasma glucose during fasting conditions by 
promoting breakdown of store liver glycogen, a process called hepatic 
glucose production. It also promotes hepatic gluconeogenesis and 
hepatic ketogenesis and brings the dropped blood glucose back to the 
normal range (26).  
 
1.5.2.3. Somatostatin  
Somatostatin is secreted by pancreatic δ-cells upon glucose 
stimulation after food intake. It inhibits insulin and glucagon release from 
pancreatic islets to prolong the absorption of nutrients by the tissues. It 
prevents quick depletion of nutrients in the bloodstream (27).  
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1.5.2.4. Pancreatic polypeptide  
 Pancreatic polypeptides (PP) are secreted by pancreatic F 
cells. Its secretion is stimulated after exercise, fasting and acute 
hypoglycemia. It inhibits gallbladder contraction and secretion of 
pancreatic digestive enzymes (28).  
 
 
2. Diabetes Mellitus 
2.1. Overview  
Glucose homeostasis is primarily maintained by pancreatic 
hormone, insulin, which enhances glucose storage or regulates 
glycogen breakdown, keeping the blood glucose level within a controlled 
range (29). When the β-cells produce insufficient amount of insulin or 
when the body cannot use the insulin properly, it leads to uncontrolled 
high blood glucose level or hyperglycemia, which is the hallmark of 
diabetes mellitus (30, 31). Diabetes mellitus is a group of metabolic 
disorders characterized by impaired glucose homeostasis resulting from 
impaired insulin secretion, insulin sensitivity, or both (32, 33). The 
number of people suffering from diabetes mellitus has been rising 
rapidly in the past three decades. In addition, diabetes mellitus is 




2.2. Symptoms  
As the duration of diabetes gets longer, the chronic 
hyperglycemia of diabetes brings serious complications such as 
blindness, neuropathy, heart attacks, stroke and kidney failure (36). In 
addition, uncontrolled diabetes may also lead to stupor, coma, 
ketoacidosis or non-ketotic hyperosmolar syndrome which could result 
in death (32, 37). 
 
2.3. Classification of Diabetes Mellitus   
According to the classical classification of diabetes proposed by 
the American Diabetes Association (ADA), there are four different types 
of diabetes; type 1 diabetes (T1D), type 2 diabetes (T2D), gestational 
diabetes mellitus (GDM) and diabetes due to other causes such as 
cystic fibrosis, treatment of HIV/AIDS or after organ transplantation (38). 
 
2.3.1. Type 1 Diabetes (T1D)  
Type 1 Diabetes constitutes 5-10% of diabetes patients (39). It 
occurs due to autoimmune β-cell destruction, usually leading to absolute 
insulin deficiency and is more dominant in children and adolescents 
(32).  
 
2.3.2. Type 2 Diabetes (T2D) 
About 90-95% of diabetes patients belong to Type 2 Diabetes, 
which are observed mostly in adults (40). Progressive loss of β-cell 
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insulin secretion frequently on the background of insulin resistance 
develops hyperglycemia (41).   
 
2.3.3. Gestational diabetes mellitus (GDM)   
Gestational diabetes is diagnosed in the second or third trimester 
of pregnancy. Hyperglycemia in pregnancy is caused by not enough 
insulin production or related to the hormonal changes of pregnancy that 
make the body less able to use insulin (41).   
 
2.3.4. Other types   
 Specific types of diabetes occurs due to other causes such as 
monogenic diabetes syndromes (e.g. neonatal diabetes and maturity-
onset diabetes of the young), diseases of the exocrine pancreases (e.g. 
cystic fibrosis and pancreatitis), and drug- or chemical induced diabetes 
(e.g. treatment of HIV/AIDS or after organ transplantation) (41).  
 
 
3. Mechanisms of Insulin Secretion 
3.1. Overview  
It is well known that upon elevation of blood glucose level, 
pancreatic β-cells secretes insulin, which is described as glucose-
stimulated insulin secretion (GSIS) (42).  
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3.2. Electrical activity in pancreatic β-cells   
Although pancreatic β-cells are not neuronal cells, insulin 
secretion in β-cells is associated with a complex electrical activity in the 
β-cells, which is characterized by a slow membrane depolarization along 
with bursts of action potentials (43). In fact, pancreatic β-cells share a 
large number of similarities with neuronal cells (44). Both cells express 
molecules such as glutamic acid decarboxylase (45), tyrosine 
hydroxylase (46), dopamine β-hydroxylase (47), type II voltage-
dependent sodium channel (48), glutamate receptor (49), neurofilament 
proteins (50, 51), receptors for neurotrophins (52, 53), and thyrotropin-
releasing hormone (54, 55). The resting membrane potential of β-cells 
is -60 ~ -70 mV with no electrical activities. The elevation of extracellular 
glucose gradually develops depolarization which activates voltage gated 
calcium channel (VGCC) in β-cells. Calcium influx through the VGCC 
triggers exocytosis of insulin granules (56). 
   
3.3. KATP–channel dependent pathway   
The primary pathway regulating the glucose-stimulated insulin 
secretion is through the activity of ATP-sensitive K+ (KATP) channels (57). 
Extracellular glucose is transported into the β-cells by glucose 
transporter 2 (GLUT2) and metabolized by glycolysis which increases 
intracellular ATP/ADP ratio. The increased ATP level leads to closure of 
the KATP channel, which in turn evokes the depolarization of β-cells (58, 
59) followed by the exocytosis of insulin granules from β-cells (56, 60, 
22 























Figure 3. The mechanism of glucose-stimulated insulin secretion 
from the β-cells 
Modified from (1)  
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3.4. KATP–channel independent pathway   
Although the main triggering pathway for the glucose-stimulated 
insulin secretion is the KATP-dependent pathway, the involvement of KATP 
channel-independent pathways in the membrane depolarization 
induced by high glucose stimulation in β-cells has been also proposed 
(62-65). For example, electrical activity of β-cells is still triggered by 
glucose even when the KATP channel is non-functional (63) or in its gene-
deleted mice (66-68).  
 
3.4.1. Swelling-stimulated insulin secretion   
As one of the candidate mechanisms for the KATP channel-
independent insulin secreting pathways, β-cell swelling is considered in 
many studies (69-71). Without changes in extracellular glucose level, 
hypotonic stimulation still triggers insulin secretion in β-cells (62, 64, 72) 
Exposed to high concentration of glucose, metabolites, such as lactate, 
accumulate inside the β-cells that increases intracellular osmolality and 
induces water influx. Importance of metabolite accumulation is also 
proved in other study, as a non-metabolizable glucose analogue, 3-O-
methylglucose, failed to evoke depolarization upon β-cell swelling (71, 
73). Therefore, dependent on the glucose metabolism, high glucose 
induces swelling in β-cells and stimulates insulin secretion. As a 
mechanism underlying the swelling-stimulated insulin secretion, 
involvement of volume-regulated anion channels or stretch activated 
cation channels is proposed (Figure 4). 
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Figure 4. Mechanism of swelling-induced insulin secretion in β-
cells 













4.1. Overview  
Mechanotransduction is referred to as the conversion of physical 
forces such as exercise, hemodynamic factors and osmotic change into 
biochemical signals (74). There are three steps required for the 
mechanotransduction: (1) the mechanical stimulus is sensed by the 
receptor cell; (2) the deformation ins transduced into an electrical 
signals; (3) the receptor potential is transmitted to the nervous system 
through action potentials (75).  
 
4.2. Mechanically gated ion channels  
Mechanically activated ion channels have pores in the plasma 
membrane, and mechanical stimuli increases their open probability (76). 
Upon mechanical stimulation, the passive diffusion of ions down their 
electrochemical gradient generates the membrane current (76). The 
best known mechanosensitive ion channels are potassium channels, 
TREK-1 and TRAAK, DEG/ENaC, TRP channels, TMC channels, and 
piezo channels (77). Recently one additional ion channel, TTN3, has 
been identified to be mechanosensitive (78).      
 
4.3. Mechanosensitivity of pancreatic β-cells  
Some of non-sensory cells and tissues derived from 
mesenchyme including endothelial cells are mechanosensitive. 
Pancreatic β-cells are derived from endodermal epithelium and are 
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known to be mechanosensitive (69). Indeed, mechanosensitive TRP 
channels are expressed in β-cells, and glucose stimulated insulin 
secretion is inhibited by mechanosensitive channel blockers (65). Cell 
swelling is well known indirect way of mechanical stimuli in pancreatic 
β-cells (69). Swelling leads to the stretch of the cell membrane, which in 
turn opens volume regulated or stretch-activated channels (71, 79). 
 
4.3.1. Volume-regulated anion channels  
Volume regulated anion channels is one of the promising 
candidates regulating the swelling stimulated insulin secretion pathway 
as it is activated by changes in cell volume (69). Several evidences 
showed that VRAC plays an important role in insulin secretion in β-cells: 
hypotonicity induced swelling of β-cells activated VRAC (62, 64); high 
glucose induced anionic currents resembling VRAC currents in β-cells 
(80, 81); and both glucose induced anionic currents and swelling-
stimulated insulin secretion are blocked by a VRAC blocker, DCPIB (82). 
Recent studies found that SWELL1 (LRRC8A) mediates anion currents 
stimulated by high glucose induced swelling in mouse pancreatic β-cells 
(83, 84). Upon glucose-induced β-cell swelling, SWELL1 activation 
induced membrane depolarization and activation of VGCC-triggered 
calcium signaling, followed by insulin secretion. In addition, Swell1 KO 
mice show impaired glucose stimulated insulin secretion which is further 
exacerbated in mild obesity (83, 84).  
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4.3.2. Stretch-activated cation channels  
Besides anion channels, the possible involvement of cation 
channels is also proposed in the swelling-stimulated insulin secretion, 
for several studies showed that glucose stimulated Ca2+ influx is not fully 
abolished with chloride blockers in KATP channel deficient β-cells (65, 85, 
86). Indeed, its channel activity was observed as SAC channel blockers, 
such as gadolinium, amiloride, 2-APB, and ruthenium red, inhibit the 
swelling-stimulated insulin secretion in murine pancreatic β-cells (65, 
69). Some transient receptor potential (TRP) channels, such as TRPV4 
and TRPV2, have been proposed as candidate genes for SAC channels, 
however, there were no direct evidences that these TRP channels 
mediate the glucose-stimulated insulin secretion in β-cells (87, 88). 
Therefore, the molecular identity of SAC channel responsible for the 




5.1. Overview  
Our lab recently identified Tentonin 3 (TTN3/TMEM150C) as a 
cation channel activated by mechanical stimulation with unique slow 
inactivation kinetics (Figure 5) (78). TTN3 is a protein with 249 amino 
acids and have two paralogs, TTN1 and TTN2, with 26.5 % and 28.1 % 
similarity, respectively. It is also expressed in human (96 % similarity) 
and rat (99% similarity) (78).  
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Figure 5. Slowly activating mechanosensitive currents evoked by 
TTN3 




5.2. Function  
Mechanosensitive sensory input is essential in muscle 
coordination as the motor commands to one effector according to the 
sensory feedback from another effector (89). Ttn3 KO mice showed less 
time clinging to an inverted grid and longer time to cross the beam. In 
addition, it showed an abnormal gait on the Catwalk automated gait 
analysis test. Hence, TTN3 regulates motor coordination by mediating 
mechanical transduction (78).  
 
5.3. Expression profile   
Tissue distribution assay using RT-PCR analysis shows that 
along with the dorsal-root ganglion neurons, TTN3 also expresses 











Figure 6. Expression profiles of TTN3 genes 







Purpose of the study 
 
Glucose homeostasis maintains the blood glucose level within a 
narrow range by secreting two glucoregulatory hormones, glucagon and 
insulin from the pancreas. After having a meal. The pancreas secretes 
insulin which brings glucose to tissues for respiration. These bring the 
blood glucose level drop back to the normal range. 
The primary pathway triggering the glucose-stimulated insulin 
secretion is through KATP-channel dependent pathway. But, the 
involvement of KATP–channel independent pathways have been also 
proposed. One of the candidates is high glucose-induced swelling 
stimulation. Swelling could activate two types of ion channels, volume 
regulated anion channel and stretch activated cation channel. Recently, 
the molecular identity of the anion channel was found that 
SWELL1/LRRC8A mediates anionic currents in response to β-cell 
swelling, however the molecular identity of the stretch activated cation 
channel remains unknown. 
Previously, we confirmed that a novel mechanosensitive cation 
channel, TTN3, is highly expressed in pancreas (Figure 6). In the 
present study, we determined whether TTN3 mediates high glucose 






1. Animals  
All animal experiments were conducted in accordance with 
protocols approved by the Institutional Animal Care and Use Committee 
(IACUC) at the Korea Institute of Science and Technology and ethical 
committee for animal welfare of the Seoul National University. 
TMEM150C knock out (KOMP, USA) male mice, ages 8-10 weeks, were 
used for experiments (78).  
  
2. Immunohistochemistry  
The pancreas tissue was fixed in formalin before embedding in 
paraffin, and cut in 5 μm serial sections. After deparaffinization with 
xylene and wash with serial dilutions of ethanol, sections were 
dehydrated followed by antigen retrieval. Primary antibodies used are; 
insulin (mouse monoclonal, sc-8033, 1:500), glucagon (mouse 
monoclonal, G2654,1:2000), amylase (mouse monoclonal, sc-46657, 
1:500), mPiezo1 (rabbit polyclonal, NBP1-78537, 1:200), and TTN3 
(rabbit polyclonal, manufactured, 1:200). Primary antibodies were 
detected by secondary antibodies conjugated to Alexa Flour 488 
(A21202, 1:2000, Life Technology) and Alexa Flour 594 (A10072, 
1:2000, Life Technology). Nucleus was stained using Hoechst 33342 
(H3570, 1:5000, Thermo fisher Scientific). Images were captured using 
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a Zeiss LSM700 confocal laser scanning microscope (Carl Zeiss, 
Germany). 
 
3. RNA interference  
siRNA sequences were designed from the mouse TMEM150C 
sequence and synthesized by Bioneer (Korea). The sequences of three 
different siRNAs against TMEM150C used in calcium and insulin 
secretion assays were as follows:  
 
(siRNA1) 5’-GCUUGUGGAUAGUGUACUU-3’;  
(siRNA2) 5’-CUUGUGGAUAGUGUACUUU-3’;  
(siRNA3) 5’-CAGAAGCUUCUGAAUAUCA-3’.  
 
Negative control siRNAs provided by the manufacturer were 
used as control. Mixture of those three different siRNAs targeting TTN3 
were transfected using RNAiMax (13778-030, Invitrogen) according to 
the manufacturer’s protocol. RNA cells were processed and analyzed 
after 48 h of transfection. 
 
4. RT-PCR  
Total RNA was extracted using easy-spin TM Total RNA 
Extraction kit (17211, Intron, Korea) according to the manufacturer’s 
instructions. Thereafter, cDNA was synthesized from 1 μg total RNA 
using SuperScript III (18080, Invitrogen, USA). RT-PCR was carried out 
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using DreamTaq Green DNA Polymerase (EP0712, Thermo Scientific, 
USA). Primers used for amplifying Ttn3 were:  
 
(Forward) 5’-GCGCTTCATCCAGCTAAAAC-3’ and  
(Reverse) 5’-AAGTACGCCAGGAAGCACAT-3’. 
 
5. Primary culture of pancreatic β-cells  
Mice were anesthetized using intraperitoneal injection of 
Zoletil (25 mg/kg) and Rumpon (10 mg/kg). Islets of Langerhans were 
isolated by injection of 4 ml HBSS containing 0.8 mg/ml collagenase P 
(11213865001, Roche, Germany) into the common bile duct. The 
pancreas was removed and incubated for 15 min in a water bath at 
37°C. Islets were purified on Biocoll gradient (L6155, Biochrom, UK) and 
further isolated by two rounds of handpicking. Islets were cultured in 
RPMI 1640 medium (11875, Gibco, USA) supplemented with 10% FBS, 
penicillin (100 U/ml), and streptomycin (0.1 mg/ml) at 37°C and 5% CO2. 
For patch clamp and calcium imaging, islets were dispersed into single 
cells by trypsin digestion. 
 
6. Cell Culture  
For cell culture studies, pancreatic β-cell lines, NIT-1, were 
cultured in RPMI 1640 medium (11875, Gibco, USA) supplemented with 
10% FBS, 100 U/ml penicillin, and 0.1 mg/ml streptomycin. HEK293T 




7. Calcium Measurements 
NIT-1 cells, grown in 96-well plates, were incubated with Fluo-4 
NW (F36206, Invitrogen, USA) for 1 h at 37°C and washed with isotonic 
(290 mOsm/kg) buffer solution. Fluo-4 NW was excited at 488 nm and 
emitted at 535 nm. The ratio of the fluorescence change, F/F0, was 
plotted to represent the changes in intracellular Ca2+ levels in response 
to 20 mM glucose or hypotonic (210 mOsm/kg) solution using SPARK 
10M Multi reader (Tecan, Switzerland). Isolated pancreatic β-cells were 
loaded with Fura-2-AM (F1221, Molecular Probes, USA) HBSS buffer at 
37°C for 30 min. The cells were perfused with isotonic (290 mOsm/kg) 
buffer solution and changed with either high glucose (20 mM) or 
hypotonic (210 mOsm/kg) solutions. Depolarization of the cells with 30 
mM KCl was used as positive control at the end of the measurement. 
Fluorescent signals in single β-cells were imaged every 3 s via 340 nm 
excitation and 380 nm emission filters. All imaging data were collected 
by Meta Flour software (Molecular Devices, USA). The ratios of 
fluorescence were calculated and analyzed using a digital fluorescence 
analyzer (MetaFlour, Molecular Devices, USA) (90). For both 
measurements, isotonic (290 mOsm/kg) buffer solution contained (in 
mM): 85 NaCl, 5 KCl, 1.2 MgCl2, 1.2 CaCl2, 10 HEPES, 2.8 Glucose, 
and 100 D-mannitol (pH7.4). Hypotonic (210 mOsm/kg) buffer contained 
(in mM): 85 NaCl, 5 KCl, 1.2 MgCl2, 1.2 CaCl2, 10 HEPES, and 2.8 
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Glucose (pH7.4). High glucose (20 mM) buffer contained (in mM): 85 
NaCl, 5 KCl, 1.2 MgCl2, 1.2 CaCl2, 10 HEPES, 2.8 Glucose, and 100 D-
mannitol (pH7.4). 
 
8. Electrophysiology  
For recording currents in HEK293T or primary β-cells, 
intracellular potential (pipette voltage) was clamped at – 60 mV. Whole 
cells were formed after rupturing the membrane under a glass pipette. 
The tip resistance was 2-3 MΩ. The junctional potential was canceled to 
zero when the tip was immersed to the bath solution. Currents were 
amplified with an Axopatch 200B amplifier (Molecular devices, USA), 
filtered at 10 kHz (Low pass Bessel filter) and sampled at either 5 or 10 
kHz (Digidata 1440A, Molecular Devices, USA). For current clamp 
recordings, bias current was not injected. Data were analyzed using 
programs written in MATLAB (MathWorks, USA). Resting membrane 
potentials were measured as averaged membrane potential for 10 s 
before applying high glucose or hypotonic stimulations. The number of 
action potentials, firing rates, peak voltage, and amplitude were 
measured as baseline subtracted averages during the firing activity of 
the cell.  
 
9. Solutions  
For recording current responses to mechanosensitivity in primary 
β-cells and hypotonicity in HEK293T cells, the basal extracellular 
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solution contained (in mM): 90 NaCl, 2 KCl, 1 MgCl2, 1 CaCl2, 10 
HEPES, and 90 D-mannitol (pH7.2), while hypotonic solution contained 
the same components with the exemption of D-Mannitol. The pipette 
solution contained (in mM): 130 CsCl, 2 MgCl2, 10 HEPES, 2 Mg-ATP, 
0.2 Na-GTP and 30 D-mannitol (pH 7.2). To block Cl- current, Na-
gluconate solution was used; the isotonic (287 mOsm/kg) bath solution 
contained (in mM): 100 Na-Gluconate, 2 CaCl2, 10 HEPES, 90 D-
Mannitol (pH 7.21). Hypotonic solution contained the same components 
with the exemption of D-Mannitol. Osmolality was also adjusted with 
mannitol for 20mM glucose stimulation. The intracellular solution (287 
mOsm/kg) contained (in mM): 100 Na-Gluconate, 10 HEPES, 90 D-
Mannitol (pH 7.21). For current clamp recordings, the isotonic (280 
mOsm/kg) bath solution consisted of (in mM): 85 NaCl, 5 KCl, 10 
HEPES, 1.2 MgCl2, 1.2 CaCl2, and 90 D-mannitol (pH 7.3 with NaOH). 
For hypotonic (200 mOsm/kg), osmolarity was adjusted with D-
mannitol. Glucose concentration for standard bath solution was either 0 
mM or 2.8 mM, whereas high glucose stimulation was by 20 mM 
Glucose. The pipette solution contained (in mM): 138 KCl, 10 NaCl, 1 
Mg Cl2, 10 HEPES, 10 EGTA (pH 7.3 with KOH), 5 ATP, and 0.1 GTP.  
 
10. Mechanical Stimulation  
Mechanical stimulations were carried out as described previously 
(78). Briefly, a fire-polished thin glass electrode (tip diameter 3–4 μm) 
was positioned at an angle of ~50° to the cell surface. Controlled by a 
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micromanipulator (Nano-controller NC4; Kleindiek Nanotechnik), the 
glass probe moved downward in a series of mechanical steps in 1 μm 
during the ramp segment of the command. The typical duration of the 
mechanical stimulation was 600 ms. 
 
11. Glucose Tolerance Test  
For glucose tolerance tests, mice were fasted for 16 h and then 
injected with D-Glucose (2 g/kg body weight). Blood samples were 
collected via the tail at 0, 15, 30, 45, 60, and 120 min after intraperitoneal 
glucose injection. Glucose levels were measured by OneTouch Ultra 
blood glucose meter (LifeScan, USA). 
 
12. Insulin Tolerance Test  
For insulin tolerance tests, mice were fasted for 6 h and then 
injected with Humulin R (0.5 U/kg). Blood samples were collected via 
the tail at 0, 15, 30, 60, and 120 min after intraperitoneal insulin injection. 
Glucose levels were measured by OneTouch Ultra blood glucose meter 
(LifeScan, USA). 
 
13. Insulin Secretion Assay  
NIT-1 cells were cultured in 6-well plates and washed twice with 
glucose-free HEPES-balanced Krebs-Ringer-Bicarbonate buffer 
(KRBH) and then pre-incubated with glucose-free Rosewell Park 
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Memorial Institute 1640 medium for 2 h at 37°C and in 5% CO2. Cells 
were then pre-incubated in KRBH buffer for 1 h at 37°C and in 5% CO2. 
After removal of the pre-incubation solution, the cells were incubated in 
KRBH buffer containing low (2.5 mM) glucose or high (16.7 mM) glucose 
solution for 1 h. Incubation media was collected, and the amount of 
insulin was measured using ELISA (ALPCO, Salem). The insulin level 
was adjusted for total cellular protein of cell lysate. The measurement 
from the plate of cells with the control medium stimulated by low glucose 
was considered as 100% of glucose-stimulated insulin secretion. For 
serum insulin measurement, blood samples were collected via the tail 
at 0, 10, 20 and 30 min after intraperitoneal glucose injection (2 g/kg 
body weight). After centrifugation at 2500 rpm, Ultra Sensitive Mouse 
Insulin ELISA Kit (90080, Crystal Chem, USA) was used to determine 
the serum insulin values. 
 
14. Statistics  
Data are presented as means ± S.E.M. Comparisons between 
groups were performed by two tailed unpaired Student’s t test. Multiple 
comparisons of the means were analyzed with one-way ANOVA with 







1. The expression of TTN3 in pancreatic β-cells  
Previous finding revealed that TTN3 shows high mRNA 
expression level in mouse pancreas (78). To further analyze detailed 
localization pattern of TTN3 in pancreas, sections of mouse pancreas 
were stained with TTN3 antibody together with pancreatic cell markers. 
Surprisingly, pancreatic cells that are insulin-positive only expressed 
TTN3 (Figure 7), while an exocrine marker, amylase, or an alpha cell 




Figure 7. Immunofluorescence analysis of TTN3 in mouse 
pancreas 
Immunofluorescence staining of TTN3 (red) and insulin (green, upper 
panels), glucagon (green, middle panels), or amylase (green, lower 
panels) in mouse pancreas sections. Scale bar represents 50 µm.  
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2. Primary cell culture of β-cells from Ttn3 KO mouse  
2.1. TTN3 systemic KO mouse   
To analyze the role of a novel cation channel TTN3 in β-cells, we 
used TTN3 knockout (KO) mouse. Mouse was generated by the trans-
National Institutes of Health Mouse Initiative Knockout Mouse Project. 
Insertion of LacZ sequence with stop codon between the exons 5 and 6 
of the Ttn3 locus resulted in the constitutive KO (non-conditional) mouse 
model (Figure 8) (78) . 
 
2.2. Islet morphology of WT and Ttn3 KO mice 
We analyzed the islet morphology of WT and Ttn3 KO mice 
appeared grossly similar and normal (Figure 9), indicating that β-cell 
itself is intact from the loss of Ttn3. 
 
2.3. Isolation of pancreatic islets   
Pancreatic islets were isolated and purified using Biocoll 
gradients (Figure 10A). We conducted mRNA expression level in mouse 
β-cell line, NIT-1 cells, and pancreatic islets isolated from wild type (WT) 
mice and Ttn3 KO mice. Ttn3 transcripts were observed in NIT-1 cells 





2.4. Expression of TTN3 in mouse pancreatic islets and β-cell 
line 
For the functional study of TTN3, isolated islets were further 
dissociated into single β-cells using trypsin, and β-cells were identified 
by their large size and granular morphology (91, 92). These dissociated 
cells clearly displayed TTN3 and insulin co-expression (Figure 11). In 
addition, α-cells are electrically active in the absence of glucose unlike 
β-cells as they express different types of voltage-gated Ca2+ channels 
(93, 94). So, identifying β-cells by their morphology and inactivation at 






Figure 8. Schematic illustration of constitutive Ttn3 KO mouse 














Figure 9. Islet morphology of Ttn3 KO mice 
(A) Representative photographs of freshly isolated pancreatic islets 
from WT (left) and TTN3 KO mice (right). Scale bars: 200 μm.  
(B) Pancreatic islets from WT and Ttn3 KO mice stained with 






Figure 10. Isolation of mouse pancreatic islets 
(A) Representative photographs of freshly isolated pancreatic islets 
from WT mice. Scale bars: 200 μm. Freshly isolated pancreatic islets 
are further incubated in trypsin and dispersed into single cells.  
(B) RT-PCR analysis for gene expression of TTN3 in mouse pancreatic 
β-cell line, NIT-1, and pancreatic islets of WT and Ttn3 KO mice. 





Figure 11. Immunofluorescence analysis of single pancreatic β-cell 
Immunofluorescence staining of TTN3 (red) and insulin (green) in 








3. TTN3 conducts mechanosensitive responses in 
mouse pancreatic β-cells 
As TTN3 was initially identified as a mechanosensitive cation 
channel with distinct inactivation kinetics, we investigated if the slowly 
adapting currents to mechanical stimuli are observed in isolated β-cells. 
Using patch clamp technique, mechanical steps were applied on the 
isolated β-cells (Figure 12A). Indeed, the unique biophysical property of 
TTN3, the slowly adapting mechanically activated currents, were 
observed in WT β-cells (Figure 12B and D), but the currents were not 
observed in Ttn3 KO β-cells (Figure 12C and D). These data indicate 
that TTN3 mediates mechanosensitive responses in mouse pancreatic 







Figure 12. Mechanosensitive currents in β-cells 
(A) The schematic diagram shows how mechanical stimulation is given 






(B-C) Representative traces of mechanically-activated inward currents 
elicited by different membrane displacement steps in primary β-cells 
from WT (A) and Ttn3 KO (B) mice.  
(D) Summary of peak amplitude of mechanically-activated currents 
measured in WT and Ttn3 KO primary β-cells (n = 7-10). Data are 













4. TTN3 is activated by hypotonicity-induced 
swelling 
4.1. Overview  
For cellular function, maintenance of a constant volume is 
essential against disturbances of body fluid osmolality (95). Upon 
external stimulations, acute cell swelling is occurred which is often 
followed by regulatory volume decrease (RVD). This restoration is 
achieved by activation of potassium and chloride conductance. Efflux of 
these ions followed passively by water is a key step in RVD (96). Volume 
regulated anion channels, playing a pivotal role in RVD, is ubiquitously 
expressed in mammalian cell (96, 97).  
 
4.2. Activation of TTN3 by hypotonicity induced swelling in 
HEK 293T cells 
In previous study on TTN3, its activation was studied only using 
a direct mechanical stimulation. Hypotonicity-induced cell swelling is an 
indirect way of mechanical stimuli (69). So, we next determined whether 
TTN3 is also activated by the indirect mechanical stimuli, swelling. We 
transfected Ttn3 to human embryonic kidney 293T (HEK293T) cells and 
stimulated by hypotonic (200 mOsm/kg) solution. As HEK293T cells 
innately expressed endogenous VRAC channels that evoke large 
inward currents to hypotonic solution (Figure 13A). These currents were 
blocked by a chloride channel blocker, fluoxetine (100 μM) (98) (Figure 
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13B). In HEK293T cells transfected with Ttn3, however, the hypotonic 
solution induced robust inward currents even in the presence of 100 μM 
fluoxetine (Figure 13C). The current-voltage relationship was further 
determined to confirm that ionic flux observed in Ttn3-overexpressed 
HEK293T cells in the presence of fluoxetine is cationic currents (Figure 
13D). TTN3 is activated by hypotonicity-induced cell swelling.  
 
4.3 Activation of TTN3 by hypotonicity induced swelling in 
isolated pancreatic β-cells 
We next explored the swelling mediated cationic currents by 
TTN3 in isolated pancreatic β-cells. To exclude the involvement of 
anionic currents in response to volume change, intracellular Cl- was 
replaced with the impermeable anion, Na-gluconate (99) (Figure 14A). 
The application of hypotonic (200 mOsm/kg) solution robustly evoked 
inward currents in isolated β-cells of WT mice, while the currents were 




   
 
Figure 13. TTN3 activation by swelling in HEK293T cells 
(A-B) Representative trace of hypotonicity (210 mOsm/kg)-induced 
currents in HEK293T cells transfected with Gfp in control bath solution 
(A) and in the presence of 100 μM fluoxetine, a volume-regulated anion 
channel blocker (B). Note a complete block of volume-regulated anion 
channel current by fluoxetine.    
(C) Representative traces of hypotonicity (210 mOsm/kg)-induced 
currents in HEK293T cells transfected with Ttn3 in the presence of 100 
μM fluoxetine. Note a robust current evoked by the hypotonicity in the 
presence of fluoxetine. 
(D) Summary of amplitudes of hypotonicity-induced currents in 
HEK293T cells transfected with Gfp or Ttn3 in the absence or presence 
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of fluoxetine (n = 8-13). *** p < 0.001, one-way ANOVA with Tukey’s 
post-hoc test.  
(E) Representative current-voltage (I-V) relationships of hypotonicity-
induced currents in HEK293T cells expressing Gfp or Ttn3 in the 
absence (dark grey) or presence of fluoxetine.  
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Figure 14. TTN3 activation by swelling in pancreatic β-cells 
(A) In order to block anion currents, both the pipette and bath solutions 
contained sodium gluconate as main charge carriers.  
(B-C) Representative traces of hypotonicity (210 mOsm/kg)-induced 
currents in primary β-cells from WT (B) and Ttn3 KO (C) mice.  
(D) Summary of amplitude of the hypotonicity-induced currents in WT 
and Ttn3 KO primary β-cells (n = 10 / genotype). *** p < 0.001, Student’s 
t test. 
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5. TTN3 is activated by high glucose-induced 
swelling 
We next determined whether glucose-induced swelling is also 
sufficient to evoke currents through TTN3 in β-cells, as high glucose 
results in β-cell membrane stretch due to the osmolality changes derived 
by the accumulation of metabolites (69-71). Similar to the hypotonic 
stimulation, the application of high glucose (20 mM) also evoked inward 
currents in WT pancreatic β-cells, but the responses were significantly 
reduced in Ttn3 deficient β-cells (Figure 15A-C). These data suggest 
that TTN3 mediates cationic currents upon high glucose-induced 




Figure 15. TTN3 activation by glucose in pancreatic β-cells 
(A-B) Representative traces of high glucose (20 mM)-induced currents 
in β cells from WT (A) and Ttn3 KO mice (B). Both the pipette and bath 
solutions contained sodium gluconate as main charge carriers. 
(C) Summary of amplitude of glucose-induced inward currents in WT 
and Ttn3 KO primary β-cells (n = 14 / genotype). * p < 0.05, Student’s t 
test.   
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6. TTN3 activation contributes to the glucose-evoked 
depolarization of β-cells   
Pancreatic β-cells are excitable cells eliciting action potential 
firings in response to glucose stimulation (100, 101). In order for β cells 
to secrete insulin, the cells need to be depolarized first. The electrical 
activity is initiated by ion fluxes throughout the β cells, such as Ca2+, Na+ 
(102) and Cl- (103). As shown in Figure 15, the loss off TTN3 reduced 
high glucose mediated cationic currents in β cells, we thus asked 
whether ablation of TTN3 could also contribute to the action potentials 
in β cells. Therefore, we determined if TTN3 contributes to the glucose-
induced electrical activities of β-cells. Application of 20 mM glucose to 
isolated β-cells induced barrage of action potential firings along with 
depolarization (Figure 16A and Figure 17). However, glucose-induced 
spiking rates and membrane depolarization in Ttn3 KO β-cells 
decreased significantly compared to those of WT β-cells (Figure 16B 





Figure 16. Electrical activities to glucose stimulation in β-cells 
(A-B) Representative traces of high glucose (20 mM)-evoked electrical 




Figure 17. Analysis of electrical activities to glucose stimulation 
(A-D) Summary of membrane depolarization (A), action potential firing 
rates (B), resting membrane potentials (RMP) (C), and amplitude of the 
firing activities (D) observed in WT and Ttn3 KO primary β-cells in 
response to high glucose (20 mM) stimulation (n = 10-15). * p < 0.05, 
Student’s t test 
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7. TTN3 activation contributes to the swelling-
evoked depolarization in β-cells 
We also determined contribution of TTN3 in swelling-stimulated 
depolarization in β-cells. Similarly, hypotonic (200 mOsm/kg) stimulation 
of β-cells from both genotypes evoked depolarization with action 
potential firings. In contrast, β-cells from Ttn3 KO mice showed 
significantly reduced firing rates as well as depolarization (Figure 18 and 
Figure 19). The resting membrane potentials and amplitude of the firings 
of WT and Ttn3 KO β-cells in response to both glucose- and hypotonic-
stimulations were comparable (Figure 19). These results suggest that 
TTN3 is responsible for the electrical activity induced by glucose 








Figure 18. Electrical activities to hypotonic stimulation in β-cells 
(A-B) Representative traces of hypotonicity (210 mOsm/kg)-evoked 




Figure 19. Analysis of electrical activities to hypotonic stimulation 
(A-D) Summary of membrane depolarization (A), action potential firing 
rates (B), resting membrane potentials (RMP) (C), and amplitude of the 
firing activities (D) observed in WT and Ttn3 KO primary β-cells in 
response to hypotonic (210 mOsm/kg) stimulation (n = 10-15). * p < 




8. TTN3 evokes Ca2+ influx to glucose stimulation 
8.1. Calcium and Exocytosis  
Subsequent to membrane depolarization, insulin secretion 
involves membrane docking, tethering and fusion of insulin granules. 
Insulin granules are defined into two groups depending on the site they 
are located. Those granules, pre-docked at the membrane and has 
interaction with SNARE and Ca2+-regulated proteins, are called a readily 
releasable pool and the other granules, triggered only for the prolonged 
stimulation, are defined as a reserve pool (104, 105). For insulin granules 
to be secreted from the plasma membrane of β-cells, release from the 
fusion regulatory protein repressor, complexin, is required. Binding of 
Ca2+ to synaptotagmin, a Ca2+ sensor in the membrane of the pre-
synaptic axon terminal, inhibits complexin and proceeds granules fusion 
and insulin secretion (106, 107). Consequently elevation of intracellular 
concentration of Ca2+ ([Ca2+]i) is significant mediator of GSIS in 
pancreatic β-cells (61). 
 
8.2. TTN3-mediated Ca2+ influx in β-cell line, NIT-1 
We determined the intracellular Ca2+ concentration, [Ca2+]i, of 
pancreatic β-cells to glucose- and hypotonic-stimulations. The 
application of high glucose (20 mM) solution elevated [Ca2+]i rapidly in 
NIT-1 cells treated with scrambled small interfering RNA (siRNA). In 
contrast, the glucose-induced increase in [Ca2+]i in N1T-1 cells 
transfected with Ttn3 siRNA was significantly reduced (Figure 20). 
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Likewise, the hypotonic solution (210 mOsm/kg) caused a rapid 
elevation in [Ca2+]i in scrambled siRNA-transfected NIT-1 cells, whereas 
Ttn3-siRNA transfected NIT-1 cells showed a significant decrease in the 
Ca2+ influx (Figure 21). The knock down of TTN3 was confirmed by RT-
PCR (Figure 22).  
 
8.3. TTN3-mediated Ca2+ influx to glucose stimulation in β-
cells 
Effects of TTN3 in the influx of Ca2+ to glucose stimulation in β-
cells was observed. Similar to the β-cell line, NIT-1, glucose stimulation 
also evoked a sustained increase in [Ca2+]i in WT β-cells whereas Ttn3 
KO primary β-cells showed significantly reduced Ca2+ responses (Figure 
23). KCl (30 mM)-induced increase in [Ca2+]i demonstrated that the β-
cells are electrically viable in both genotypes (Figure 23). Together, 
these data demonstrate that TTN3 mediates glucose- and hypotonicity-
induced Ca2+ influx in pancreatic β-cells. TTN3 mediates glucose-
induced Ca2+ influx in pancreatic β-cells. 
 
8.4. TTN3-mediated Ca2+ influx to hypotonic stimulation in β-
cells 
We next measured the changes in [Ca2+]i of pancreatic β-cells to 
hypotonic stimulation. Hypotonic stimulation evoked a rise in [Ca2+]i in 
WT β-cells. In contrast, the degree of increase in [Ca2+]i was reduced in 
Ttn3 KO primary β-cells (Figure 24). Treatment of high (30 mM) KCl 
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solution confirmed its electrical viability (Figure 24). TTN3 mediates 





Figure 20. Glucose-stimulated Ca2+ influx in NIT-1 cells 
(A) Average traces of intracellular Ca2+ to high glucose (20 mM) 
stimulation in Fluo-4 NW loaded mouse pancreatic β-cell line, NIT-1 
cells, transfected with scrambled (grey) or Ttn3 siRNA (cyan). 
(B) Mean peak values of Fluo-4 NW fluorescence ratio in WT (grey) and 
Ttn3 knock-down NIT-1 cells (cyan) to glucose stimulation (n = 6-9 









Figure 21. Swelling-stimulated Ca2+ influx in NIT-1 cells 
(A) Average traces of intracellular Ca2+ to hypotonic (210 mOsm/kg) 
stimulation in Fluo-4 NW loaded mouse pancreatic β-cell line, NIT-1 
cells, transfected with scrambled (grey) or Ttn3 siRNA (cyan). 
(B) Mean peak values of Fluo-4 NW fluorescence ratio in WT (grey) and 
Ttn3 knock-down NIT-1 cells (cyan) to hypotonic stimulation (n = 7 wells 







Figure 22. Knockdown of TTN3 in β-cell line, NIT-1 
Treatment of siRNA targeting TTN3 decreased mRNA level of TTN3 in 





Figure 23. Glucose-stimulated Ca2+ influx in pancreatic β-cells 
(A) Average traces of intracellular Ca2+ of Fura-2 loaded primary β-cells 
from WT (grey) and Ttn3 KO mice (cyan) to high glucose (20 mM) 
stimulation. High KCl (30 mM) solution (arrow) was challenged to 
confirm cellular excitability.  
(B) Mean peak values of the Fura-2 ratio (340/380 nm) from isolated WT 
(grey) and Ttn3 KO (cyan) primary β-cells to high glucose stimulation. 
Fluorescence intensity was measured every 3 s (n = 22 / genotype). *** 




Figure 24. Swelling-stimulated Ca2+ influx in pancreatic β-cells 
(A) Average traces of intracellular Ca2+ of Fura-2 loaded primary β-cells 
from WT (grey) and Ttn3 KO mice (cyan) to hypotonic (210 mOsm/kg) 
stimulation. High KCl (30 mM) solution (arrow) was challenged to 
confirm cellular excitability.  
(B) Mean peak values of the Fura-2 ratio (340/380 nm) from isolated WT 
(grey) and Ttn3 KO (cyan) primary β-cells to hypotonic stimulation. 
Fluorescence intensity was measured every 3 s (n = 22 / genotype). ** 








9. TTN3-mediated Ca2+ influx and other pathways 
9.1. KATP channel-mediated Ca2+ influx  
The depolarization evoked by the closure of the KATP channel 
largely accounts for the increase in glucose-induced [Ca2+]I (108). 
Therefore, to exclude KATP channel-derived Ca2+ influx in response to 
glucose stimulation, we treated an opener of KATP channel, diazoxide 
(109). In the presence of 100 μM diazoxide, WT pancreatic β-cells 
displayed a small but robust elevation of [Ca2+]i in response to high 
glucose (20 mM). Surprisingly, the small elevation of [Ca2+]i was reduced 
in Ttn3 KO β-cells (Figure 25).  
 
9.2. VRAC channel  
In addition, swelling-stimulated [Ca2+]I can also derived by two 
types of channels, stretch activated cation channel and VRAC. To 
determine whether TTN3-mediated [Ca2+]I is related to the VRAC 
channel pathway, we blocked VRAC channel by fluoxetine (100 uM). 
The result showed that hypotonic stimulation still evoked a rapid and 
sustained increase in [Ca2+]i in WT primary β-cells, whereas in Ttn3 KO 





Figure 25. TTN3 mediates Ca2+ influx, independent of KATP-channel 
in response to glucose stimulation 
(A) High glucose (20 mM)-induced intracellular Ca2+ of Fura-2 loaded 
primary β-cells from WT and Ttn3 KO mice in the presence of KATP 
channel opener, diazoxide (100 μM).  
(B) Mean peak values of Ca2+ transients of primary β-cells from WT and 
Ttn3 KO mice in the presence of diazoxide (n = 20-23 ). * p < 0.05, 




Figure 26. TTN3 mediates Ca2+ influx, independent of VRAC-
channel in response to hypotonic stimulation 
(A) Hypotonicity (210 mOsm/kg)-induced intracellular Ca2+ in Fura-2 
loaded primary β-cells from WT and Ttn3 KO mice in the presence of 
volume-regulated anion channel blocker, fluoxetine (100 μM).  
(B) Mean peak values of Ca2+ transients of primary β-cells from WT and 
Ttn3 KO mice in the presence of fluoxetine (n = 20 / genotype). ** p < 
0.01, Student’s t test.  
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10. Impaired glucose tolerance and insulin secretion 
in Ttn3 KO mice 
10.1. TTN3-mediated insulin secretion in NIT-1 cells.   
Based on previous findings that the loss of TTN3 decreases Ca2+ 
influx and electrical activity of β-cells upon high glucose and hypotonic 
solutions, we next asked whether decreased Ca2+ influx in TTN3 KO β-
cells eventually leads to a reduction in insulin secretion and glucose 
tolerance. The amount of insulin released upon glucose stimulation was 
measured in NIT-1, treated with the scrambled siRNA or Ttn3 siRNA. 
The application of high glucose (16.7 mM) solution to NIT-1 cells treated 
with scrambled siRNA induced 2.5-fold increase in insulin secretion 
compared to that of low glucose (2.5 mM) application. In contrast, the 
application of high glucose solution to NIT-1 cells transfected with Ttn3 
siRNA induced 1.6-fold increase in insulin secretion compared to that of 
the low glucose application to these cells (Figure 27).   
 
10.2. Ttn3 KO mice show higher blood glucose level upon 
glucose stimulation.    
To determine the physiological role of TTN3 in glucose-
stimulated insulin secretion, we assessed effects of Ttn3 ablation on the 
ability to metabolize glucose. Next, the intraperitoneal (i.p.) glucose 
tolerance test was conducted in WT and Ttn3 KO mice that were fasted 
overnight (16 h). I.p. injection of glucose (2 g/kg body weight) elevated 
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the blood glucose level in both genotypes. The basal blood glucose 
levels of both genotypes were comparable, however, Ttn3 KO mice 
showed the significantly impaired glucose tolerance at 15min after the 
injection (Figure 28).  
 
10.3. Insulin sensitivity is preserved in Ttn3 KO mice.    
As the ablation of Ttn3 leads to the impaired glucose tolerance, 
we questioned whether the impaired glucose tolerance is due to 
decreased insulin sensitivity. Thus, we conducted i.p. insulin tolerance 
test (IPITT), where the serum glucose levels at different time points are 
measured before and after the injection of insulin (0.5 U/kg) in fasted (6 
h) mice. As shown in Figure 29, blood glucose levels from both 
genotypes for two hours after the i.p. injection of insulin in fasted mice 
were identical, indicating that the loss of Ttn3 does not alter the insulin 
sensitivity.  
 
10.4. Decreased insulin secretion in Ttn3 KO mice.    
We next determined the effects of TTN3 on the glucose-
stimulated insulin release in vivo. Serum insulin levels in every 10 min 
for the first 30 min after injection of glucose (2 g/kg body weight) in fasted 
(16 h) mice were measured. As shown in Figure 30, the injection of 
glucose elevated the serum insulin level in both genotypes in 10 min 
after the glucose stimulation. However, the serum insulin level in Ttn3 
deficient mice was significantly lower than that of WT mice. These 
78 
results suggest that the genetic ablation of Ttn3 leads to impaired 
glucose tolerance due to the decreased insulin secretion. 
 
10.5. Role of TTN3 in Diabetic disease models.    
Next, we examined the effects of genetic ablation of TTN3 in 
mouse diabetic disease models. HFD feeding is used to induce mild 
obesity, a state of pre-diabetes (110). We induced diabetes by high fat 
feeding (HFD; 60% fat) for 12 weeks in mice and observed metabolic 
characteristics. Both genotypes gradually increased their body weight 
upon high fat diet, but Ttn3 KO mice gained weight at faster rate and 
were significantly heavier compared to WT mice (Figure 31) with no 
differences in the amounts of water intake and food intake (Figure 32).  
Further studies are needed to determine what causes weight gain in 





Figure 27. Measurement of insulin secretion in NIT-1 cells 
Glucose-stimulated insulin secretion of NIT-1 cells treated with Ttn3 
siRNAs or scrambled siRNA to low glucose (LG, 2 mM) and high 
glucose (HG, 20 mM) (n = 5 ). *** p < 0.001, Student’s t test. 
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Figure 28. Ttn3 KO mice show higher blood glucose level 
Intraperitoneal glucose tolerance (IPGTT). The level of glucose in serum 
were measured in 16hr fasting WT and Ttn3 KO mice before and after 





Figure 29. Sensitivity to Insulin is preserved in Ttn3 KO mice 
Intraperitoneal insulin tolerance (IPITT). The level of glucose in serum 
were measured in 6hr fasting WT and Ttn3 KO mice before and after 
insulin injection (0.5U / body weight) (n = 8 / genotype). ** p < 0.01, 




Figure 30. Decreased insulin secretion in Ttn3 KO mice 
Glucose-stimulated insulin secretion. The levels of insulin in serum were 
measured in WT and Ttn3 KO mice at every 10 min after the 
administration of glucose (2 g/kg body weight) (n = 14 / genotype). * p < 












Figure 31. Effects of HFD on body weight in Ttn3 KO mice 
WT and Ttn3 KO mice were placed on high fat diet (HFD), or the 
nutritionally matched low fat control diet (CD) for 12 weeks. Mice were 
weighted once a week. (n = 5-6 / CD, n = 8-11 / HFD). * p < 0.05, ** p < 










Glucose homeostasis is tightly regulated by pancreatic endocrine 
hormones, insulin and glucagon, which lowers and raises blood glucose, 
respectively. Not like other parts of the body, the brain cannot store 
glucose and mostly depends on the glucose in the bloodstream 
(12). Therefore, it is important to maintain a constant level of blood 
glucose, which process is known as glucose homeostasis. 
Diabetes mellitus is a metabolic disease that the blood glucose level is 
not maintained within a controlled range due to impaired insulin 
sensitivity or insufficient insulin secretion from pancreatic β-cells (30, 
31). Moreover it is followed by severe complications such as retinopathy, 
neuropathy, nephropathy and atherosclerosis (35). Molecular 
mechanisms underlying the glucose-stimulated insulin secretion in 
pancreatic β-cells have been studied intensely. The involvement of KATP 
channel in the insulin secretion becomes the leading pathway for the 
glucose-stimulated insulin secretion. However, an alternative pathway 
for the glucose-stimulated insulin secretion are also suggested (62-65). 
SAC channel activity is suggested for one of the alternative mechanisms 
for the glucose-stimulated insulin secretion (65, 69). The molecular 
identity of SAC channel, however, remained unknown. In the present 
study, we suggest that TTN3 is an additional regulator for glucose-
stimulated insulin secretion in pancreatic β-cells (Figure 33): (1) its 
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selective expression in β-cells, (2) TTN3-like mechanosensitive currents 
in pancreatic β-cells, (3) genetic ablation of Ttn3 in pancreatic β-cells 
leads to decreased Ca2+ influx and electrical activity in response to 
glucose stimulation, and (4) Ttn3 gene deletion leads to impaired 
glucose tolerance with decreased insulin secretion in vivo.  
Glucose-stimulated insulin secretion is regulated by cytoplasmic 
concentration of Ca2+, which mediates membrane docking, tethering 
and exocytosis of insulin granules (111). A number of studies unveiled 
the mechanism of Ca2+ signaling in pancreatic β-cells upon glucose 
stimulation (56, 112). The source of intracellular Ca2+ increase is the 
extracellular Ca2+ through voltage-gated Ca2+ channel, which is 
activated by β-cell depolarization (113, 114). The major component 
responsible for the β-cell depolarization is thought to be the closure of 
KATP channels (115). However, several studies suggest that the KATP 
channel is not the sole ionic mechanism underlying the depolarization 
and predict the presence of additional contributors for the depolarization 
of β-cells(58, 62, 116). In line with this notion, swelling of the β-cells 
induced by glucose is also considered as a significant factor stimulating 
insulin secretion (65, 71). Exposed to high concentration of glucose, 
glycolysis in the β-cells is accelerated and leads to an intracellular 
lactate accumulation (71, 73, 117). The accumulation of lactate results 
in intracellular hyper-osmolality that draws water via aquaporin 7 into the 
cell (79, 118, 119). Even in the absence of glucose, osmotic swelling of 
β-cells induced insulin secretion (62, 64, 72). Thus, swelling itself is one 
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of the triggering pathways to insulin secretion. 
The role of volume-regulated anion channel (VRAC) in β-cells 
has been studied (69-71). VRAC can depolarize β-cells because they 
mediate the efflux of anion, Cl-. In fact, the equilibrium potential of Cl- is 
relatively high (-30 mV) in β-cells, which leads to the depolarization of 
the cell(64, 120). The molecular identity of the VRAC was identified to 
be SWELL1/LRRC8a (121). Recently, it has been shown that SWELL1 
has an important role in glucose sensing and therefore enhancing insulin 
secretion as SWELL1 deficient mice showed impaired glucose tolerance 
and insulin secretion (83, 84).  
The presence of SAC channels along with the VRAC in 
pancreatic β-cells has been also suggested as their blockers such as 
gadolinium, amiloride, 2-APB, and ruthenium red inhibit the swelling-
stimulated insulin secretion in β-cells (65, 69). In addition, the treatment 
of anion channel blockers to β-cells partially blocked the swelling-
induced Ca2+ influx or insulin secretion (85, 86). The present study 
showed that mechanical step stimuli evoked currents with slow 
inactivation kinetics that are absent in β-cells of Ttn3 KO mice. Ttn3 
overexpressing cells responded to hypotonic solution. Cationic currents 
and intracellular Ca2+ increase evoked by hypotonic solution were 
markedly reduced in Ttn3 deficient β-cells. Thus, these data suggest 
that TTN3 may be a key component of SAC channels in β-cells, which 
sense mechanical tension of the plasma membrane and transduce it to 
electrical activity β-cells.  
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TTN3 has been recently determined as a mechanosensitive non-
selective cation channel (78). In addition, independency of TTN3’s 
function as a mechanosensor was questioned (122, 123). Here, the 
dependency of TTN3 on Piezo1 may also be questioned, but recent 
study determined that Piezo1 is expressed in acinar cells and is involved 
in pancreatitis (124). In addition, immunohistochemistry staining for 
Piezo1 in mouse pancreatic tissue revealed that Piezo 1 is not 
expressed in insulin-secreting β-cells (Figure 34). Therefore, the role of 
TTN3 in pancreatic β-cells as a mechanosensor and a mediator of Ca2+ 




Figure 33. Mechanism of swelling-stimulated insulin secretion in β-
cells through TTN3 
Schematic illustration shows high concentration of glucose initially 
evokes β-cell inflation, which then activates VRCC (cyan, e.g. TTN3) 
and VRAC (blue, e.g. SWELL1), respectively. TTN3 alone mediates 
cationic influx into the cell. Also, influx of cations (black arrow) and efflux 
of chloride ions (grey arrow) depolarize the cell membrane leading to 
VGCC activation. These cellular events increase cytosolic Ca2+ 
concentration promoting insulin vesicle fusion and insulin release in 
pancreatic β-cells (Bold blue arrows) depict a novel mechanism of TTN3 




Figure 34. Immunofluorescence analysis of Piezo1 in mouse 
pancreas 
Immunofluorescence staining of mPiezo1 (red) and insulin (green, 
upper panels), glucagon (green, middle panels), or amylase (green, 






We questioned whether TTN3 contributes to the depolarization 
evoked by glucose-induced swelling in pancreatic β-cells. Using 
immunohistochemistry, we observed its expression in mouse pancreatic 
β-cells. Electrophysiological studies revealed that TTN3 mediates 
cationic currents in response to the hypotonicity-induced and high 
glucose-induced swelling in pancreatic β-cells. TTN3 activation by 
swelling and high glucose evoked depolarization along with the 
electrical activities in β-cells. Independent of KATP-channel and VRAC 
channel mediated pathway, increase in Ca2+ influx was also observed 
upon hypotonic and glucose stimulations. In addition, ablation of Ttn3 
resulted in impaired glucose tolerance with decreased insulin secretion. 
Consequently, in this study we suggest that TTN3 mediates swelling-
stimulated cationic currents in pancreatic β-cells and regulates glucose-
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국 문 초 록 
포도당은 인체의 에너지원으로 중요한 물질이다. 세포는 
해당과정(glycolysis)과 미토콘드리아 내 유기호흡을 통해 포도당을 
인체의 에너지 형태인 ATP (아데노신 삼인산)로 합성한다. 과다하게 
섭취된 포도당은 호르몬 인슐린에 의해 글리코겐이라는 형태로 
간에 저장되어 혈당이 떨어지는 경우, 호르몬 글루코겐에 의해 다시 
포도당으로 전환 되어 혈액을 통하여 다른 세포들에게 전달된다. 
하지만 뇌와 같은 장기는 혈액 내 포도당에만 의존하여 에너지를 
공급 받기에 혈액 내 일정한 포도당 농도를 유지하는 것이 뇌의 
기능을 위해 중요하다.   
당항상성은 주로 췌장에서 분비 되는 호르몬에 의해 
조절된다. 혈당의 높낮이는 췌장 내 랑게르한스섬에 의해 감지 되어 
호르몬들이 분비되는데, 저혈당의 경우 글루카곤이, 고혈당의 경우 
인슐린이 분비된다. 췌장 베타세포에서 인슐린 분비 기전으로는 
ATP-sensitive potassium (KATP) 채널에 의존하는 기전이 가장 잘 
알려져 있다. 혈액 내 포도당은 췌장 베타세포의 운반체인 GLUT2 
(Glucose transporter)를 통해 세포 내로 유입되어 대사과정에 의해 
ATP가 생성되는데, ATP의 증가는 KATP 채널의 통로를 닫는다. 
칼륨(K)이 세포 내에 축적 되면 세포막의 탈분극이 일어나고, 이는 
전압의존성 칼슘채널을 열어 세포내 칼슘 농도를 증가시킨다. 
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칼슘은 인슐린과 세포막의 융합을 유도하여 세포외배출을 일으킨다. 
하지만 이와 더불어 KATP 채널에 의존하지 않는 또 다른 인슐린 
분비 기전이 존재한다는 것이 알려져 있다. 고농도의 포도당이 
대사전달에서 생성되는 젖산에 의해 삼투압에 따른 세포 팽창을 
일으키고, 세포막의 수축에 따라 부피 감지 음이온채널 및 기계적 
자극 감지 양이온채널들을 활성화 시킬 것이라고 알려져 있지만 
이들의 분자적 정보는 잘 알려져 있지 않다.   
최근 우리 실험실에서는 오감각의 하나인 촉각, 즉 기계적인 
자극에 의해 조절되는 양이온 전류가 TMEM150C/Tentonin 
3(TTN3) 채널에 의해 조절된다는 것을 밝혔다. 선행연구에서 
TTN3 단백질이 췌장에서 높은 발현을 보이는 것을 확인하였다. 
기계적 자극을 감지하는 채널인 TTN3가 췌장 내에서 어떠한 
영향을 미치는지 알아보고자 본 연구를 시작하게 되었다. 결과로, 
TTN3가 췌장 내 인슐린을 분비하는 베타세포에 특이적으로 많은 
발현을 보이는 것을 확인하였다. TTN3가 넉아웃 된 셀에서는 
고농도의 포도당 그리고 저삼투압에 의한 양이온 전류, 그리고 
세포내 칼슘 유입이 줄어들었고, 분비되는 인슐린의 양도 줄었으며 
포도당향상성이 저하 되어있어 정상 쥐에 비해 높은 혈당을 보이는 
것을 확인하였다. 본 연구는 기계적 자극 감지 이온채널인 TTN3가 
췌장내 베타세포에서 인슐린 분비에 미치는 영향과 분자수준의 
메커니즘을 제시하였다.  
 
 
 
 
 
 
 
 
 
 
